← Open Payments lookup

THERESA MANRIQUEZ: Open Payments

NPI 1578170791 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,612 in 203 payments from 14 companies in 2025. Trend: 2023 $3,470 · 2024 $3,811 · 2025 $3,612

Food & beverage: $3,612
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.24$475
ABBVIE INC.21$445
Janssen Biotech, Inc.19$353
Salix Pharmaceuticals, a division of Bausch Health US, LLC34$330
QOL Medical, LLC13$326
Aimmune Therapeutics, Inc.23$285
Celltrion USA Inc.18$276
Gilead Sciences, Inc.11$263
Ardelyx, Inc.11$235
GENZYME CORPORATION7$187

Products named: TREMFYA, Sucraid, ENTYVIO, ZENPEP, VEGZELMA, XIFAXAN, IBSRELA, RINVOQ.

Industry payments across TX — which companies pay providers there.